Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Azurrx Biopharma Inc (NQ: AZRX )

0.8839 USD +0.0141 (+1.62%)
Streaming Delayed Price Updated: 7:26 AM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Azurrx Biopharma Inc

< Previous 1 2 3 4 5 6 Next >
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Shareholder Letter Outlines Program Highlights, Provides Business Update
From InvestorBrandNetwork
AzurRx BioPharma CEO Issues Letter to Shareholders
From GlobeNewswire News Releases
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters Agreement for Upcoming Phase 1b/2a Clinical Trial
From InvestorBrandNetwork
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
Phase 1b/2a Study Expected to Begin In 2Q 2021 
From GlobeNewswire News Releases
Nonhospitalized Long-Haul Coronavirus Patients Susceptible to Cognitive Dysfunction
From InvestorBrandNetwork
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Initiates Phase 2 RESERVOIR Trial for Treatment of COVID-19 GI Infections
From InvestorBrandNetwork
AzurRx BioPharma Initiates Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
From GlobeNewswire News Releases
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Key Results from Phase 2b OPTION 2 Clinical Trial
From InvestorBrandNetwork
AzurRx BioPharma Provides Key Takeaways from Phase 2b OPTION 2 Clinical Trial Topline Results Conference Call
From GlobeNewswire News Releases
AzurRx BioPharma to Report Topline Data from Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis
AzurRx to Host Conference Call and Live Audio Webcast Today, Wednesday, March 31, 2021 at 4:30 p.m. ET 
From GlobeNewswire News Releases
Thinking about buying stock in CASI Pharmaceuticals, Windtree Therapeutics, ChargePoint Holdings, FreightCar America, or AzurRx BioPharma?
InvestorsObserver issues critical PriceWatch Alerts for CASI, WINT, CHPT, RAIL, and AZRX. 
From PR Newswire
Research Finds That Covid-19 Infection Increases Chance of Stroke Among Patients
From InvestorBrandNetwork
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Phase 2 MS1819-PERT Combination Clinical Trial
From InvestorBrandNetwork
AzurRx BioPharma Announces Completion of Enrollment in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatment of Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficie
Top-line data expected in Q2 2021 
From GlobeNewswire News Releases
Lessons from the Fight Against COVID-19
From InvestorBrandNetwork
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Upcoming Phase 2b Clinical Trial of Cystic Fibrosis Treatment
From InvestorBrandNetwork
Thinking about buying stock in Sundial, FuelCell, Naked Brand, AzurRx, or General Electric?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, FCEL, NAKD, AZRX, and GE. 
From PR Newswire
AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis
From GlobeNewswire News Releases
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference
From InvestorBrandNetwork
AzurRx BioPharma to Present at the Maxim Group Emerging Growth Virtual Conference (March 17-18)
From GlobeNewswire News Releases
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Plans to Participate in 33rd Annual ROTH Conference, $10M Registered Direct Offering
From InvestorBrandNetwork
AzurRx BioPharma Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From GlobeNewswire News Releases
AzurRx BioPharma to Participate in the 33rd Annual Roth Conference
AzurRx Chairman and CEO, James Sapirstein, to participate in panel discussion on potential developmental therapeutics for SARS-CoV-2 infection 
From GlobeNewswire News Releases
How Therapeutic Hypothermia Could Benefit ICU Patients
From InvestorBrandNetwork
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in ‘Fireside Chat’ at Upcoming H.C. Wainwright Conference
From InvestorBrandNetwork
AzurRx BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Appoints New Chairman of the Board
From InvestorBrandNetwork
AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors
Former Chairman Edward J. Borkowski to continue as the lead independent director on the board 
From GlobeNewswire News Releases
Coronavirus Pandemic Exposes Biomedical Waste Disposal Challenge in India
From InvestorBrandNetwork
InvestorNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference
From InvestorBrandNetwork
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.